OBJECTIVES: We wanted to compare detection of a broad spectrum of human papillomavirus (HPV) types detected in cellular specimens from the vagina and cervix, which could provide information about the potential of each anatomical site for harboring infection. Previous studies have failed to present data on or detect a broad spectrum of HPV genotypes and/or have not carefully sampled the vagina, instead relying on self-collection that is likely contaminated with cervical cells. STUDY DESIGN: We conducted follow-up study of 353 women who had participated in study of HPV and cervical neoplasia in Costa Rica. We collected paired cervical and vaginal specimens; vaginal specimens were collected from the fornix to minimize cervical contamination. Specimens were tested in a masked fashion for >40 HPV types using a MY09/MY11 PCR method and type-specific dot blot hybridization. RESULTS: The prevalence for any carcinogenic HPV type in vaginal and cervical specimens was similar (P = 0.3). However, the prevalence for any HPV type in vaginal specimens was greater than in cervical specimens (P = 0.0002), primarily due to a twofold increased vaginal prevalence of HPV types of the alpha3/alpha15 phylogenetic species (e.g., HPV61) (P <0.00005). CONCLUSIONS: Carcinogenic HPV types appeared to have a similar affinity for vaginal and cervical epithelium, but noncarcinogenic HPV types of the alpha3/alpha15 phylogenetic species may have a tropism for vaginal epithelium.
OBJECTIVES: We wanted to compare detection of a broad spectrum of human papillomavirus (HPV) types detected in cellular specimens from the vagina and cervix, which could provide information about the potential of each anatomical site for harboring infection. Previous studies have failed to present data on or detect a broad spectrum of HPV genotypes and/or have not carefully sampled the vagina, instead relying on self-collection that is likely contaminated with cervical cells. STUDY DESIGN: We conducted follow-up study of 353 women who had participated in study of HPV and cervical neoplasia in Costa Rica. We collected paired cervical and vaginal specimens; vaginal specimens were collected from the fornix to minimize cervical contamination. Specimens were tested in a masked fashion for >40 HPV types using a MY09/MY11 PCR method and type-specific dot blot hybridization. RESULTS: The prevalence for any carcinogenic HPV type in vaginal and cervical specimens was similar (P = 0.3). However, the prevalence for any HPV type in vaginal specimens was greater than in cervical specimens (P = 0.0002), primarily due to a twofold increased vaginal prevalence of HPV types of the alpha3/alpha15 phylogenetic species (e.g., HPV61) (P <0.00005). CONCLUSIONS:Carcinogenic HPV types appeared to have a similar affinity for vaginal and cervical epithelium, but noncarcinogenic HPV types of the alpha3/alpha15 phylogenetic species may have a tropism for vaginal epithelium.
Authors: Aimée R Kreimer; Hormuzd A Katki; Mark Schiffman; Cosette M Wheeler; Philip E Castle Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-01 Impact factor: 4.254
Authors: Melinda Butsch Kovacic; Philip E Castle; Rolando Herrero; Mark Schiffman; Mark E Sherman; Sholom Wacholder; Ana C Rodriguez; Martha L Hutchinson; M Concepción Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Robert D Burk Journal: Cancer Res Date: 2006-10-15 Impact factor: 12.701
Authors: Xavier Castellsagué; Mireia Díaz; Silvia de Sanjosé; Nubia Muñoz; Rolando Herrero; Silvia Franceschi; Rosanna W Peeling; Rhoda Ashley; Jennifer S Smith; Peter J F Snijders; Chris J L M Meijer; F Xavier Bosch Journal: J Natl Cancer Inst Date: 2006-03-01 Impact factor: 13.506
Authors: Heidi E Jones; Bruce R Allan; Janneke H H M van de Wijgert; Lydia Altini; Sylvia M Taylor; Alana de Kock; Nicol Coetzee; Anna-Lise Williamson Journal: J Clin Microbiol Date: 2007-04-04 Impact factor: 5.948
Authors: Philip E Castle; Jose Jeronimo; Mark Schiffman; Rolando Herrero; Ana C Rodríguez; M Concepción Bratti; Allan Hildesheim; Sholom Wacholder; L Rodney Long; Leif Neve; Ruth Pfeiffer; Robert D Burk Journal: Cancer Res Date: 2006-01-15 Impact factor: 12.701
Authors: P E Gravitt; J V Lacey; L A Brinton; W A Barnes; J R Kornegay; M D Greenberg; S M Greene; O C Hadjimichael; L McGowan; R Mortel; P E Schwartz; R Zaino; A Hildesheim Journal: Cancer Epidemiol Biomarkers Prev Date: 2001-02 Impact factor: 4.254
Authors: Philip E Castle; Mark Schiffman; Andrew G Glass; Brenda B Rush; David R Scott; Sholom Wacholder; Anne Dunn; Robert D Burk Journal: J Infect Dis Date: 2006-11-03 Impact factor: 5.226
Authors: Mark Schiffman; Rolando Herrero; Rob Desalle; Allan Hildesheim; Sholom Wacholder; Ana Cecilia Rodriguez; Maria C Bratti; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Martha Hutchinson; Thomas C Wright; Diane Solomon; Zigui Chen; John Schussler; Philip E Castle; Robert D Burk Journal: Virology Date: 2005-06-20 Impact factor: 3.616
Authors: Rolando Herrero; Philip E Castle; Mark Schiffman; M Concepción Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Mark E Sherman; Sholom Wacholder; Sabrina Chen; Ana C Rodriguez; Robert D Burk Journal: J Infect Dis Date: 2005-05-02 Impact factor: 5.226
Authors: Rachel L Winer; James P Hughes; Qinghua Feng; Long Fu Xi; Stephen Cherne; Sandra O'Reilly; Nancy B Kiviat; Laura A Koutsky Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-12-20 Impact factor: 4.254
Authors: Cosette M Wheeler; William C Hunt; Jack Cuzick; Erika Langsfeld; Amanda Pearse; George D Montoya; Michael Robertson; Catherine A Shearman; Philip E Castle Journal: Int J Cancer Date: 2012-06-20 Impact factor: 7.396
Authors: Mark Schiffman; Andrew G Glass; Nicolas Wentzensen; Brenda B Rush; Philip E Castle; David R Scott; Julie Buckland; Mark E Sherman; Greg Rydzak; Peter Kirk; Attila T Lorincz; Sholom Wacholder; Robert D Burk Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-05-20 Impact factor: 4.254
Authors: Anne F Rositch; Michelle I Silver; Anne Burke; Raphael Viscidi; Kathryn Chang; Cindy M P Duke; Wen Shen; Patti E Gravitt Journal: J Low Genit Tract Dis Date: 2013-01 Impact factor: 1.925
Authors: Marco H Schulze; Fabian M Völker; Raimond Lugert; Paul Cooper; Kai Hasenclever; Uwe Groß; Herbert Pfister; Steffi Silling Journal: Med Microbiol Immunol Date: 2016-09-06 Impact factor: 3.402
Authors: Vikrant V Sahasrabuddhe; Patti E Gravitt; S Terence Dunn; David Brown; Richard A Allen; Yolanda J Eby; Katie Smith; Rosemary E Zuna; Roy R Zhang; Michael A Gold; Mark Schiffman; Joan L Walker; Philip E Castle; Nicolas Wentzensen Journal: J Clin Microbiol Date: 2013-11-06 Impact factor: 5.948